Search
valrubicin (Valstar)
Indications:
- bladder cancer
- intravesical therapy of BCG-refractory carcinoma in situ of the urinary bladder
- cystectomy is not an option
Dosage:
- 800 mg intravesically once a week for 6 weeks
- use four 5 mL single use vial 40 mg/mL (800 mg)
- dilute with 55 mL normal saline to a volume of 75 mL
Adverse effects:
- urinary symptoms
- urinary frequency, urgency
- dysuria
- urinary incontinence
- hematuria
Interactions
drug adverse effects of anthracyclines
General
anthracycline
References
- RxList
http://www.rxlist.com/valstar-drug.htm
- Deprecated Reference